Children's Hospital Corporation

Children's Hospital Corporation was paid $330.79M by Medicaid between Jan 2018 and Dec 2024, across 852 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 5.3% of everything it billed.

33Billing provider infoCHILDREN'S HOSPITAL CORPORATION
BOSTON, MA 02115

33aNPI1710087127assigned 09/25/2006

33bProvider typeClinic/Center

28Total paid$330.79M

24GClaims4,733,583

24DCodes billed852

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Clinic/Center providers in Massachusetts

Rank by total paid#2 of 53

Median peer was paid$154K

This provider vs. median2,149×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	628,849	$41.15M
2019	654,186	$42.16M
2020	491,774	$38.20M
2021	685,918	$46.59M
2022	765,925	$53.27M
2023	801,039	$57.96M
2024incomplete	705,892	$51.47M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	5.3%	135,081	120,422	$17.63M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	4.1%	74,790	71,232	$13.49M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	3.5%	75,695	69,771	$11.68M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	3.5%	57,792	55,576	$11.55M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	3.1%	4,984	4,559	$10.36M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	3.0%	10,656	9,573	$10.01M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	2.9%	36,285	34,272	$9.70M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	2.3%	8,437	5,933	$7.73M
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	2.3%	4,042	3,113	$7.55M
41899	Unlisted procedure, dentoalveolar structures	2.2%	4,012	3,807	$7.22M
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	2.1%	4,364	4,306	$6.99M
42820	Tonsillectomy and adenoidectomy; younger than age 12	2.1%	3,109	3,088	$6.79M

840 more codes

96361	Intravenous infusion, hydration; each additional hour	1.7%	8,492	$5.54M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.6%	5,455	$5.27M
J3490	Unclassified drugs	1.4%	17,887	$4.55M
70551	Magnetic resonance imaging, brain; without contrast material	1.4%	12,440	$4.54M
G0378	Hospital observation service, per hour	1.3%	34,661	$4.28M
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	1.3%	14,615	$4.22M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.2%	13,274	$3.84M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.1%	14,927	$3.68M
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	1.1%	30,078	$3.61M
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	1.1%	1,640	$3.57M
90834	Psychotherapy session, about 45 minutes	1.0%	10,878	$3.41M
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	63,187	$3.26M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	29,844	$3.18M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	18,811	$3.18M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	4,158	$3.13M
76770		<1%	16,075	$3.10M
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	3,109	$3.08M
49452		<1%	2,643	$2.94M
99215	Doctor's office visit, returning patient (complex)	<1%	14,452	$2.84M
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	<1%	1,212	$2.74M
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	27,851	$2.69M
D2930	Prefabricated stainless steel crown - primary tooth	<1%	17,246	$2.67M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	2,165	$2.46M
42830		<1%	1,128	$2.23M
D1120	Dental cleaning, child	<1%	49,812	$2.20M
54161		<1%	1,087	$2.08M
95782		<1%	1,739	$2.01M
97803		<1%	25,407	$2.00M
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	19,849	$2.00M
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	14,881	$1.92M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	19,937	$1.86M
92567		<1%	34,355	$1.81M
93325		<1%	18,820	$1.80M
D7140	Extraction, erupted tooth or exposed root	<1%	22,293	$1.73M
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	20,651	$1.71M
92587		<1%	9,292	$1.66M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	1,056	$1.64M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	12,459	$1.59M
99219		<1%	11,764	$1.46M
92610		<1%	10,554	$1.43M
D1206	Topical application of fluoride varnish	<1%	64,475	$1.42M
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	34,700	$1.41M
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	7,270	$1.36M
D0120	Dental checkup, returning patient	<1%	53,894	$1.34M
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	50,181	$1.32M
94010		<1%	11,938	$1.26M
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	17,171	$1.23M
95819		<1%	3,372	$1.14M
D8670	Periodic orthodontic treatment visit	<1%	7,432	$1.12M
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	59,850	$1.09M
97802		<1%	13,024	$1.09M
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	5,821	$1.08M
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	7,860	$1.06M
87631		<1%	9,483	$1.02M
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	3,430	$987K
64640		<1%	1,092	$985K
96375	Therapeutic injection; each additional sequential IV push	<1%	14,917	$964K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	11,294	$959K
36430		<1%	2,176	$951K
71046	Radiologic examination, chest; 2 views	<1%	29,320	$914K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	12,034	$901K
29075		<1%	3,178	$860K
D1351	Sealant - per tooth	<1%	30,184	$845K
92555		<1%	11,111	$833K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	17,832	$830K
D1110	Prophylaxis - adult	<1%	13,844	$787K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	114,872	$785K
95708		<1%	1,624	$770K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	5,732	$768K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	6,112	$767K
74230		<1%	4,290	$746K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	24,534	$715K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	7,467	$715K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	24,737	$711K
51600		<1%	1,452	$707K
72082		<1%	8,591	$697K
D2392	Resin-based composite - two surfaces, posterior, primary or permanent	<1%	7,817	$686K
92579		<1%	11,702	$654K
92607		<1%	5,457	$650K
99173		<1%	22,921	$647K
84443	Thyroid stimulating hormone (TSH)	<1%	44,121	$631K
D0272	Bitewings - two radiographic images	<1%	25,570	$620K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	3,343	$616K
29065		<1%	2,229	$608K
97161		<1%	5,880	$608K
81229		<1%	968	$575K
95953		<1%	742	$570K
90837	Psychotherapy session, about an hour	<1%	1,127	$566K
J2704	Injection, propofol, 10 mg	<1%	44,079	$565K
D2391	Resin-based composite - one surface, posterior, primary or permanent	<1%	7,957	$558K
D8080	Comprehensive orthodontic treatment of the adolescent dentition	<1%	715	$557K
87632		<1%	3,607	$549K
S9485	Crisis intervention mental health services, per diem	<1%	951	$545K
86003		<1%	9,545	$541K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	3,969	$533K
92060		<1%	7,077	$531K
D0140	Limited oral evaluation - problem focused	<1%	13,684	$513K
76820		<1%	4,535	$505K
D0330	Panoramic radiographic image	<1%	8,910	$500K
97162		<1%	3,955	$499K
92523		<1%	3,743	$498K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	87,024	$496K
51741		<1%	1,947	$491K
D0150	Comprehensive oral evaluation - new or established patient	<1%	9,876	$485K
92552		<1%	4,608	$457K
96127		<1%	9,658	$453K
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	65	$448K
82728		<1%	37,047	$447K
90791	Psychiatric diagnostic evaluation	<1%	894	$433K
92582		<1%	8,570	$430K
92558		<1%	12,308	$426K
92611		<1%	3,958	$420K
76886		<1%	2,587	$394K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	9,890	$391K
77072		<1%	5,957	$380K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	2,760	$365K
88307		<1%	1,185	$363K
73521		<1%	6,053	$361K
D0274	Bitewings - four radiographic images	<1%	10,487	$360K
95812		<1%	623	$360K
82784		<1%	28,397	$357K
92557		<1%	3,176	$355K
12011		<1%	1,239	$339K
85027		<1%	57,667	$329K
29405		<1%	1,146	$328K
93976		<1%	2,056	$325K
54640		<1%	196	$324K
76536		<1%	2,224	$323K
72081		<1%	4,108	$322K
99222	Initial hospital care, per day, moderate complexity	<1%	1,938	$316K
99381		<1%	3,153	$315K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	742	$311K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	6,195	$311K
90651		<1%	3,246	$310K
90832	Psychotherapy session, about 30 minutes	<1%	1,247	$309K
D2150	Silver amalgam - two surfaces, primary or permanent	<1%	3,645	$308K
76882		<1%	2,160	$303K
83735		<1%	53,370	$300K
72141		<1%	1,575	$297K
80053	Comprehensive metabolic panel	<1%	35,628	$293K
94618		<1%	1,898	$293K
83655		<1%	26,030	$292K
95715		<1%	304	$292K
86481		<1%	4,003	$292K
86923		<1%	5,237	$291K
74455		<1%	1,302	$287K
72197		<1%	409	$287K
76870		<1%	2,140	$285K
73610		<1%	6,870	$285K
73630		<1%	6,310	$284K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	19,679	$282K
81025		<1%	30,942	$282K
93017		<1%	2,054	$277K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	9,531	$273K
73590		<1%	5,297	$262K
84439		<1%	33,337	$262K
83970		<1%	7,586	$256K
72170		<1%	3,932	$252K
74018		<1%	4,177	$250K
D0220	Intraoral - periapical first radiographic image	<1%	16,025	$246K
90686		<1%	15,529	$240K
87799		<1%	5,621	$238K
93975		<1%	827	$235K
92250		<1%	5,311	$232K
83036	Hemoglobin; glycosylated (A1C)	<1%	26,817	$232K
81479	Unlisted molecular pathology procedure	<1%	685	$229K
99441		<1%	1,539	$228K
92551		<1%	1,752	$228K
73090		<1%	4,929	$223K
73560		<1%	4,894	$222K
73100		<1%	3,113	$219K
80048	Basic metabolic panel (calcium, ionized)	<1%	30,027	$219K
94060		<1%	1,250	$218K
A9585	Injection, gadobutrol, 0.1 ml	<1%	4,861	$215K
90846	Family psychotherapy without the patient present, 50 minutes	<1%	531	$215K
74019		<1%	9,051	$213K
92585		<1%	674	$213K
86008		<1%	2,409	$206K
76821		<1%	2,971	$203K
82248		<1%	42,797	$200K
86832		<1%	1,132	$197K
D2330		<1%	2,914	$196K
86141		<1%	16,081	$196K
90792	Psychiatric diagnostic evaluation with medical services	<1%	340	$191K
D9230	Inhalation of nitrous oxide / analgesia, anxiolysis	<1%	11,198	$191K
92340	Fitting of spectacles, except for aphakia; monofocal	<1%	9,043	$189K
73140		<1%	4,077	$188K
94726		<1%	1,583	$188K
86833		<1%	1,102	$186K
92556		<1%	4,214	$183K
93320		<1%	15,037	$183K
92553		<1%	1,618	$182K
86480		<1%	3,485	$182K
87086	Culture, bacterial; quantitative colony count, urine	<1%	25,632	$179K
88185		<1%	746	$178K
76825		<1%	2,829	$177K
44970		<1%	39	$177K
92015	Determination of refractive state	<1%	9,530	$176K
D3220	Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction	<1%	2,043	$176K
D2331		<1%	2,249	$175K
87081		<1%	30,489	$174K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	43,499	$174K
92608		<1%	3,677	$173K
83540		<1%	30,612	$167K
83550		<1%	22,599	$166K
0001A		<1%	3,841	$161K
0002A		<1%	3,616	$160K
93225		<1%	2,095	$160K
97165		<1%	1,250	$157K
80051		<1%	26,896	$157K
51728		<1%	290	$156K
86850		<1%	13,069	$155K
70486		<1%	893	$152K
77077		<1%	2,678	$152K
T2023	Targeted case management; per month	<1%	631	$152K
86140		<1%	34,055	$152K
88184		<1%	1,779	$150K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	7,621	$150K
83516		<1%	11,977	$149K
91200		<1%	1,130	$147K
82785		<1%	9,764	$147K
C1769	Guide wire	<1%	3,118	$147K
73080		<1%	3,287	$144K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	895	$143K
83001		<1%	6,527	$142K
92285		<1%	2,676	$139K
20680		<1%	42	$136K
84403		<1%	6,189	$134K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	2,460	$133K
80076		<1%	25,381	$130K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	6,036	$129K
31526		<1%	215	$126K
87077		<1%	15,166	$123K
76827		<1%	2,829	$121K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	17,766	$120K
0071A		<1%	2,657	$120K
86317		<1%	3,660	$119K
73552		<1%	2,089	$116K
86355		<1%	4,005	$116K
0399T		<1%	923	$115K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	5,158	$115K
0072A		<1%	2,527	$114K
92609		<1%	1,246	$114K
74183		<1%	374	$114K
73110		<1%	3,183	$113K
J2997	Injection, alteplase recombinant, 1 mg	<1%	691	$112K
99383		<1%	1,115	$112K
86356		<1%	1,526	$112K
96415		<1%	182	$111K
49500		<1%	29	$109K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	2,485	$108K
99442		<1%	703	$107K
82565		<1%	38,193	$107K
73130		<1%	2,760	$107K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	1,442	$106K
82805		<1%	1,676	$105K
80061	Lipid panel	<1%	19,956	$104K
92083		<1%	1,596	$103K
83002		<1%	6,500	$103K
99382		<1%	942	$103K
85045		<1%	29,147	$102K
74240		<1%	474	$99K
80050	General health panel	<1%	4,930	$99K
85652		<1%	41,606	$98K
90472	Immunization administration, each additional vaccine (list separately)	<1%	40,220	$96K
92018		<1%	173	$96K
84466		<1%	9,006	$95K
80197		<1%	9,159	$93K
24538		<1%	26	$93K
82627		<1%	4,682	$90K
D2335		<1%	714	$88K
92133		<1%	1,789	$88K
96401		<1%	14	$88K
73070		<1%	1,320	$88K
74712		<1%	354	$87K
97804		<1%	953	$87K
86360		<1%	3,550	$86K
83718		<1%	11,774	$86K
83690		<1%	14,992	$86K
85246		<1%	4,358	$86K
93226		<1%	2,097	$83K
D2140		<1%	1,218	$83K
87070		<1%	11,479	$83K
83021		<1%	4,909	$82K
84305		<1%	4,766	$82K
J1644	Injection, heparin sodium, per 1000 units	<1%	5,945	$81K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	30,137	$81K
64643		<1%	438	$80K
83520		<1%	2,611	$80K
87186		<1%	10,447	$79K
90378		<1%	194	$78K
D0230	Intraoral - periapical each additional radiographic image	<1%	7,862	$77K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	15,353	$77K
D0210	Intraoral - complete series of radiographic images	<1%	1,810	$74K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	1,053	$73K
76857		<1%	396	$73K
84146		<1%	4,489	$72K
85007		<1%	22,604	$71K
94729		<1%	1,287	$71K
86357		<1%	3,382	$70K
0054A		<1%	1,631	$70K
83880		<1%	2,565	$69K
87497		<1%	2,148	$68K
90480		<1%	1,916	$68K
85610		<1%	19,307	$68K
85730		<1%	12,898	$67K
84100		<1%	54,954	$67K
88342		<1%	2,181	$67K
99384		<1%	603	$66K
82150		<1%	10,411	$66K
92134		<1%	1,213	$65K
87040		<1%	7,379	$65K
92604		<1%	53	$63K
93356		<1%	6,855	$63K
93304		<1%	138	$63K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	949	$62K
86160		<1%	3,329	$62K
82607		<1%	4,850	$62K
90691		<1%	2,469	$61K
86803		<1%	4,826	$61K
71250		<1%	294	$60K
82040		<1%	8,360	$59K
D8660		<1%	2,780	$59K
70360		<1%	1,434	$58K
92652		<1%	862	$58K
77080		<1%	494	$57K
95816		<1%	161	$56K
D2393	Resin-based composite - three surfaces, posterior, primary or permanent	<1%	592	$56K
71555		<1%	217	$56K
70450	Computed tomography, head or brain; without contrast material	<1%	249	$56K
90670		<1%	4,690	$55K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	492	$55K
D0145	Oral evaluation for a patient under three years of age	<1%	2,192	$55K
64642		<1%	312	$54K
85055		<1%	1,822	$54K
81003		<1%	26,820	$54K
12001		<1%	193	$53K
82570		<1%	10,977	$52K
87496		<1%	1,943	$52K
72195		<1%	251	$52K
D2332		<1%	449	$52K
82247		<1%	12,429	$51K
86665		<1%	1,808	$51K
ATP16		<1%	6,303	$51K
72146		<1%	1,123	$51K
87184		<1%	5,463	$50K
ATP09		<1%	7,802	$50K
86900		<1%	13,599	$49K
87205		<1%	9,614	$49K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	6,105	$49K
82139		<1%	3,683	$48K
A0434	Specialty care transport (sct)	<1%	71	$47K
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	1,902	$46K
73564		<1%	647	$46K
84270		<1%	2,360	$46K
D9920		<1%	1,229	$46K
84702		<1%	3,646	$46K
ATP07		<1%	6,856	$46K
86901		<1%	13,165	$45K
83498		<1%	1,941	$45K
82465		<1%	14,047	$44K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	328	$44K
87046		<1%	2,273	$44K
71045	Radiologic examination, chest; single view	<1%	1,956	$44K
67311		<1%	12	$44K
76776		<1%	250	$43K
86376		<1%	3,319	$42K
29345		<1%	156	$42K
64644		<1%	369	$42K
J0690	Injection, cefazolin sodium, 500 mg	<1%	11,137	$42K
81001		<1%	15,188	$41K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	179	$41K
82397		<1%	3,011	$40K
73000		<1%	724	$39K
90715		<1%	2,248	$39K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	11,770	$39K
82379		<1%	2,908	$39K
86038		<1%	3,696	$38K
70544		<1%	321	$38K
ATP14		<1%	4,458	$38K
87467		<1%	1,249	$38K
80069		<1%	6,588	$38K
84134		<1%	3,188	$38K
86618		<1%	1,994	$37K
84460		<1%	35,309	$37K
D0340		<1%	1,311	$37K
82533		<1%	2,168	$36K
82610		<1%	2,586	$36K
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	8,371	$36K
82670		<1%	1,439	$36K
97164		<1%	398	$35K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	433	$34K
84446		<1%	3,004	$34K
86706		<1%	3,632	$34K
D0240		<1%	2,564	$34K
ATP08		<1%	4,677	$33K
95700		<1%	2,113	$33K
83525		<1%	3,280	$33K
86364		<1%	5,632	$32K
86255		<1%	1,883	$32K
82105		<1%	2,011	$32K
84590		<1%	3,489	$32K
82746		<1%	2,515	$32K
93308		<1%	168	$31K
94680		<1%	615	$31K
86834		<1%	109	$31K
90734		<1%	1,053	$30K
31624		<1%	25	$30K
82977		<1%	20,109	$30K
84132		<1%	2,710	$30K
84450		<1%	25,820	$30K
83631		<1%	1,936	$29K
84520		<1%	37,122	$29K
86774		<1%	2,173	$29K
99188		<1%	1,118	$29K
88304		<1%	2,129	$29K
84630		<1%	3,106	$29K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	602	$29K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	5,896	$29K
31622		<1%	24	$28K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	11,171	$28K
51798		<1%	1,572	$28K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	5,918	$27K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	15,906	$27K
86800		<1%	2,037	$27K
85240		<1%	1,627	$27K
0004A		<1%	659	$27K
86835		<1%	111	$27K
36000		<1%	592	$27K
80164		<1%	2,463	$26K
84156		<1%	8,490	$26K
82043		<1%	5,442	$25K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	20,128	$25K
0052A		<1%	566	$25K
85245		<1%	1,229	$25K
87209		<1%	1,291	$25K
72100		<1%	606	$24K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	1,036	$24K
ATP17		<1%	3,029	$24K
10060		<1%	108	$24K
93321		<1%	394	$24K
91322		<1%	906	$23K
90716		<1%	1,865	$23K
54163		<1%	12	$23K
86592		<1%	5,651	$22K
86352		<1%	280	$22K
ATP15		<1%	2,597	$22K
73030		<1%	611	$22K
83993		<1%	1,494	$22K
95951		<1%	39	$21K
0051A		<1%	471	$21K
80177		<1%	1,950	$21K
82525		<1%	2,015	$21K
82947		<1%	24,614	$21K
D9310		<1%	384	$21K
C1893	Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away	<1%	411	$21K
83605		<1%	2,203	$20K
85379		<1%	2,322	$20K
87106		<1%	2,076	$20K
84480		<1%	1,598	$20K
G0008	Administration of influenza virus vaccine	<1%	11,386	$20K
85384		<1%	2,548	$20K
0111A		<1%	440	$20K
90685		<1%	1,781	$20K
D1354		<1%	1,646	$19K
82542		<1%	861	$19K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	373	$19K
V5264	Ear mold/insert, not disposable, any type	<1%	441	$19K
ATP03		<1%	3,490	$19K
82652		<1%	559	$18K
82550		<1%	8,253	$18K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	2,130	$18K
90633		<1%	3,679	$18K
90680		<1%	5,299	$18K
70543		<1%	66	$18K
0112A		<1%	391	$18K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	2,310	$17K
88313		<1%	634	$17K
86341		<1%	530	$17K
87529		<1%	294	$17K
87340		<1%	1,882	$17K
82010		<1%	2,271	$17K
ATP02		<1%	4,050	$17K
87501		<1%	375	$17K
83615		<1%	13,067	$17K
83789		<1%	744	$17K
ATP04		<1%	3,036	$17K
88161		<1%	435	$17K
83721		<1%	3,531	$16K
J7030	Infusion, normal saline solution , 1000 cc	<1%	2,332	$16K
86769		<1%	405	$16K
82803		<1%	971	$16K
99203	Doctor's office visit, new patient (routine)	<1%	141	$16K
73060		<1%	338	$16K
73522		<1%	180	$15K
75573		<1%	30	$15K
80195		<1%	1,350	$15K
81002		<1%	6,891	$15K
90677		<1%	3,304	$15K
88341		<1%	217	$15K
87427		<1%	1,294	$14K
90707		<1%	1,791	$14K
81228		<1%	99	$14K
82681		<1%	1,350	$14K
D2390		<1%	108	$14K
A0425	Ground mileage, per statute mile	<1%	70	$14K
87634		<1%	257	$14K
82310		<1%	7,491	$13K
84436		<1%	2,813	$13K
73700		<1%	86	$13K
73718		<1%	53	$13K
73562		<1%	176	$12K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	428	$12K
51785		<1%	65	$12K
82272		<1%	3,624	$12K
97763		<1%	157	$12K
87177		<1%	1,284	$12K
87045		<1%	1,417	$12K
J1170	Injection, hydromorphone, up to 4 mg	<1%	6,169	$12K
0154A		<1%	270	$12K
82340		<1%	1,857	$12K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	110	$11K
81243		<1%	699	$11K
76376		<1%	1,602	$11K
82787		<1%	498	$11K
80183		<1%	959	$11K
73660		<1%	220	$11K
84145		<1%	1,220	$11K
88108		<1%	363	$11K
75557		<1%	129	$10K
ATP10		<1%	1,543	$10K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	51	$10K
ATP06		<1%	1,700	$10K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	1,557	$10K
85018		<1%	4,777	$10K
99204	Doctor's office visit, new patient (more involved)	<1%	65	$10K
90620		<1%	224	$10K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	79	$10K
69210		<1%	135	$10K
83883		<1%	899	$10K
84484		<1%	905	$10K
94760		<1%	7,985	$10K
84075		<1%	8,524	$10K
86231		<1%	1,191	$10K
86258		<1%	1,111	$9K
76000		<1%	495	$9K
94681		<1%	61	$9K
89230		<1%	193	$9K
87449		<1%	938	$9K
87338		<1%	675	$9K
86905		<1%	707	$9K
82103		<1%	719	$9K
88262		<1%	83	$9K
43762		<1%	39	$9K
0074A		<1%	190	$9K
ATP05		<1%	1,384	$9K
92524		<1%	63	$8K
90474		<1%	11,865	$8K
86235		<1%	118	$8K
J7050	Infusion, normal saline solution, 250 cc	<1%	677	$8K
V5275	Ear impression, each	<1%	577	$8K
73502		<1%	98	$8K
82017		<1%	575	$8K
87324		<1%	762	$8K
82085		<1%	974	$8K
73620		<1%	87	$8K
99157		<1%	89	$8K
72142		<1%	99	$7K
76506		<1%	61	$7K
73221		<1%	29	$7K
93243		<1%	471	$7K
86787		<1%	597	$7K
80180		<1%	404	$7K
93242		<1%	472	$7K
86664		<1%	369	$7K
90696		<1%	1,294	$7K
76642		<1%	67	$7K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	12,180	$7K
86580		<1%	332	$7K
96367		<1%	27	$7K
51797		<1%	375	$7K
84255		<1%	380	$7K
90710		<1%	1,089	$7K
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	<1%	1,397	$7K
91122		<1%	12	$7K
82330		<1%	729	$6K
80175		<1%	665	$6K
92593		<1%	89	$6K
93788		<1%	66	$6K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	14	$6K
93971		<1%	87	$6K
82390		<1%	677	$6K
72040		<1%	222	$6K
88142		<1%	340	$6K
V5160	Dispensing fee, binaural	<1%	12	$6K
99443		<1%	35	$6K
86039		<1%	609	$6K
58300		<1%	12	$6K
J3360	Injection, diazepam, up to 5 mg	<1%	1,334	$6K
D0270		<1%	412	$6K
76819	Fetal biophysical profile; without non-stress testing	<1%	70	$6K
D1208	Topical application of fluoride, excluding varnish	<1%	196	$6K
82657		<1%	210	$5K
D9248		<1%	134	$5K
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	2,559	$5K
97166		<1%	36	$5K
99402		<1%	46	$5K
ATP11		<1%	710	$5K
G0379	Direct admission of patient for hospital observation care	<1%	79	$5K
97168		<1%	44	$5K
D8999		<1%	126	$5K
97116		<1%	124	$5K
80502		<1%	287	$5K
86225		<1%	402	$5K
87536		<1%	77	$4K
90656		<1%	2,658	$4K
82960		<1%	779	$4K
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	9,826	$4K
93886		<1%	24	$4K
75565		<1%	393	$4K
84478		<1%	3,023	$4K
82140		<1%	309	$4K
D1510		<1%	20	$4K
86644		<1%	330	$4K
84550		<1%	3,524	$4K
86682		<1%	317	$4K
86308		<1%	809	$4K
86337		<1%	198	$4K
70250		<1%	139	$4K
ATP12		<1%	588	$4K
51701		<1%	4,290	$4K
82157		<1%	137	$4K
81405		<1%	16	$4K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	32	$3K
90713		<1%	295	$3K
0003A		<1%	92	$3K
72070		<1%	99	$3K
72083		<1%	37	$3K
82507		<1%	143	$3K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	3,180	$3K
86147		<1%	52	$3K
77073		<1%	55	$3K
74181		<1%	19	$3K
83986		<1%	912	$3K
86902		<1%	42	$3K
99385		<1%	27	$3K
ATP18		<1%	393	$3K
90675		<1%	28	$3K
92025		<1%	33	$3K
83010		<1%	223	$3K
88300		<1%	699	$3K
J7510	Prednisolone oral, per 5 mg	<1%	569	$2K
95012		<1%	1,703	$2K
72147		<1%	87	$2K
86704		<1%	221	$2K
A4215	Needle, sterile, any size, each	<1%	243	$2K
A4627	Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler	<1%	1,453	$2K
80230		<1%	44	$2K
86015		<1%	235	$2K
87269		<1%	148	$2K
J1265	Injection, dopamine hcl, 40 mg	<1%	840	$2K
92588		<1%	29	$2K
96376		<1%	722	$2K
89051		<1%	347	$2K
94664		<1%	26	$2K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	19	$2K
88230		<1%	30	$2K
82024		<1%	65	$2K
86431		<1%	431	$2K
86256		<1%	192	$2K
92595		<1%	26	$2K
99205	Prolong outpt/office vis	<1%	12	$2K
J1756	Injection, iron sucrose, 1 mg	<1%	675	$2K
69209		<1%	68	$2K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	63	$2K
76010		<1%	47	$2K
90714		<1%	28	$2K
V5266	Battery for use in hearing device	<1%	731	$2K
82725		<1%	115	$2K
93568		<1%	26	$2K
99177		<1%	13,551	$2K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	1,113	$2K
G0009	Administration of pneumococcal vaccine	<1%	3,984	$2K
84295		<1%	2,115	$2K
J3535	Drug administered through a metered dose inhaler	<1%	79	$2K
84155		<1%	2,506	$2K
J8540	Dexamethasone, oral, 0.25 mg	<1%	7,646	$2K
92370		<1%	35	$2K
S0077	Injection, clindamycin phosphate, 300 mg	<1%	41	$2K
76604		<1%	27	$2K
83919		<1%	140	$2K
82180		<1%	209	$2K
94727		<1%	32	$2K
84681		<1%	100	$2K
87210		<1%	780	$2K
90381		<1%	179	$2K
83930		<1%	265	$2K
83090		<1%	146	$2K
85014		<1%	763	$1K
A6250	Skin sealants, protectants, moisturizers, ointments, any type, any size	<1%	853	$1K
87522	Neg quan hep c or qual rna	<1%	38	$1K
99417	Prolong home eval add 15m	<1%	367	$1K
51792		<1%	51	$1K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	1,119	$1K
L4360	Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	1,204	$1K
L1830	Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf	<1%	510	$1K
G0010	Administration of hepatitis b vaccine	<1%	2,424	$1K
87220		<1%	312	$1K
87101		<1%	164	$1K
0296T		<1%	65	$1K
82435		<1%	1,307	$1K
90717		<1%	13	$1K
64645		<1%	100	$1K
82820		<1%	97	$1K
86880		<1%	136	$1K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	76	$1K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	683	$969.08
0297T		<1%	65	$967.74
87254		<1%	24	$912.89
ATP13		<1%	140	$903.87
83921		<1%	53	$869.37
88312		<1%	66	$863.99
86146		<1%	26	$853.10
86359		<1%	781	$851.51
88311		<1%	52	$844.02
90632		<1%	40	$822.90
70355		<1%	12	$806.60
82962		<1%	1,962	$795.09
84202		<1%	61	$791.44
84207		<1%	38	$788.00
99156		<1%	84	$771.55
0141A		<1%	35	$769.27
92341		<1%	63	$765.60
83020		<1%	59	$743.12
J1815	Injection, insulin, per 5 units	<1%	59	$743.10
V5020	Conformity evaluation	<1%	28	$727.52
80235		<1%	31	$696.59
85008		<1%	598	$693.54
86162		<1%	46	$692.78
85670		<1%	111	$681.21
76377		<1%	85	$679.55
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	<1%	222	$638.55
84999		<1%	131	$636.45
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	2,650	$617.14
D3120		<1%	18	$600.00
88346		<1%	14	$588.43
86765		<1%	40	$578.81
86945		<1%	30	$555.60
82626		<1%	24	$547.06
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	<1%	80	$526.11
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	226	$518.22
86735		<1%	38	$496.50
L3906	Wrist hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment	<1%	1,483	$473.50
Q9958	High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml	<1%	478	$456.20
90658		<1%	554	$402.06
J3475	Injection, magnesium sulfate, per 500 mg	<1%	225	$390.22
ATP19		<1%	43	$389.70
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	53	$386.09
0164A		<1%	12	$383.73
80203		<1%	42	$372.67
85660		<1%	78	$359.96
82232		<1%	28	$348.21
86645		<1%	25	$341.78
86663		<1%	29	$296.87
90473		<1%	640	$276.40
86200		<1%	29	$251.24
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	771	$244.86
84425		<1%	13	$243.36
D9420		<1%	5,027	$240.00
84210		<1%	28	$233.87
84157		<1%	53	$209.73
86684		<1%	14	$195.58
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	13	$191.75
82945		<1%	41	$181.63
86694		<1%	13	$171.95
80143		<1%	12	$164.40
51784		<1%	55	$161.74
86762		<1%	12	$160.08
80201		<1%	13	$159.90
86708		<1%	13	$135.21
81015		<1%	474	$129.40
86777		<1%	15	$127.34
83529		<1%	12	$123.88
J2305	Injection, nitroglycerin, 5 mg	<1%	14	$119.45
83051		<1%	27	$109.65
91305		<1%	848	$101.26
85732		<1%	15	$85.65
85049		<1%	17	$68.20
93288		<1%	14	$55.26
99411		<1%	16	$53.91
87299		<1%	14	$38.59
J2060	Injection, lorazepam, 2 mg	<1%	28	$38.10
91300		<1%	2,502	$37.18
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	1,222	$35.78
J1250	Injection, dobutamine hydrochloride, per 250 mg	<1%	297	$35.06
J0735	Injection, clonidine hydrochloride, 1 mg	<1%	231	$28.96
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	17	$27.02
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	87	$26.35
J0780	Injection, prochlorperazine, up to 10 mg	<1%	178	$20.74
A4344	Indwelling catheter, foley type, two-way, all silicone or polyurethane, each	<1%	25	$18.85
95873		<1%	218	$9.81
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	448	$4.70
91321		<1%	601	$4.65
82374		<1%	46	$4.30
96381		<1%	48	$1.81
J1171	Injection, hydromorphone, 0.1 mg	<1%	50	$1.76
90619		<1%	2,613	$1.00
90744		<1%	2,422	$0.26
90648		0%	1,498	$0.00
D0350		0%	2,284	$0.00
D2940		0%	279	$0.00
91311		0%	147	$0.00
90700		0%	1,525	$0.00
D9996		0%	1,293	$0.00
72149		0%	73	$0.00
J8499	Prescription drug, oral, non chemotherapeutic, nos	0%	69	$0.00
90380		0%	32	$0.00
80339		0%	26	$0.00
76001		0%	25	$0.00
J3370	Injection, vancomycin hcl, 500 mg	0%	25	$0.00
J1643	Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units	0%	66	$0.00
90661		0%	73	$0.00
D0470		0%	1,277	$0.00
90657		0%	267	$0.00
90698		0%	2,953	$0.00
91307		0%	958	$0.00
90697		0%	2,801	$0.00
D1330		0%	2,110	$0.00
D1353		0%	596	$0.00
D9995		0%	2,842	$0.00
90634		0%	436	$0.00
L4350	Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf	0%	59	$0.00
80352		0%	60	$0.00
J1940	Injection, furosemide, up to 20 mg	0%	19	$0.00
93246		0%	13	$0.00
J1836	Injection, metronidazole, 10 mg	0%	65	$0.00
90723		0%	67	$0.00
93247		0%	13	$0.00
C9285	Lidocaine 70 mg/tetracaine 70 mg, per patch	0%	16	$0.00
91315		0%	30	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCHURCHWELL, KEVIN (PRESIDENT AND CEO)

Same official

Other billing entities under CHURCHWELL, KEVIN

Full network →

Provider	Location	Paid
Children's Hospital Ambulance An INC Div of the Childrens Hosp Corp	Boston, MA	$1.83M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.